Maternal MitoQ Treatment Is Protective Against Programmed Alterations in CYP Activity Due to Antenatal Dexamethasone. - Bennett, Millicent G. A.; Meakin, Ashley S.; Botting-Lawford, Kimberley J.; Niu, Youguo; Ford, Sage G.; Murphy, Michael P.; Wiese, Michael D.; Giussani, Dino A.; Morrison, Janna L. (Pharmaceutics, 2025)